echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Amec Lidocaine and Tetracaine Cream Obtained NMPA Clinical Trial Approval

    Amec Lidocaine and Tetracaine Cream Obtained NMPA Clinical Trial Approval

    • Last Update: 2021-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 19, Amic issued an announcement stating that the application for the clinical trial of lidocaine and tetracaine cream filed on August 5, 2021 by its wholly-owned subsidiary, Beijing Nuobot Biotechnology Co.
    , Ltd.
    , has been completed in October 2021.
    On the 18th, we obtained the "Notice of Drug Clinical Trial Approval" issued by the National Medical Products Administration for clinical trials of local anesthesia on intact skin before surgery on adult superficial skin
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.